<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H7515F23226F64D81AFE4028989A38B20" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 3029 IH: Improving Low-Income Access to Prescription Drugs Act of 2019</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-05-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3029</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20190528">May 28, 2019</action-date><action-desc><sponsor name-id="O000168">Mr. Olson</sponsor> (for himself, <cosponsor name-id="B001300">Ms. Barragán</cosponsor>, <cosponsor name-id="M001158">Mr. Marchant</cosponsor>, and <cosponsor name-id="L000287">Mr. Lewis</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XVIII of the Social Security Act to provide transitional coverage and retroactive
			 Medicare part D coverage for certain low-income beneficiaries.</official-title></form>
	<legis-body id="H001445E28958498AB00B3320ECA3EFBB" style="OLC">
 <section id="H0EACEFF2491947E6A1C1034A19E14244" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Improving Low-Income Access to Prescription Drugs Act of 2019</short-title></quote>.</text> </section><section id="H05099119C4344ADE997A30C2B97C3C1B"><enum>2.</enum><header>Transitional coverage and retroactive Medicare part D coverage for certain low-income beneficiaries</header><text display-inline="no-display-inline">Section 1860D–14 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-114">42 U.S.C. 1395w–114</external-xref>) is amended—</text>
 <paragraph id="HDAC6F586FD324E63BF5E31A1463064A8"><enum>(1)</enum><text>by redesignating subsection (e) as subsection (f); and</text> </paragraph><paragraph id="H4176570FC6B445799E3B49BAE2A8FDD6"><enum>(2)</enum><text>by adding after subsection (d) the following new subsection:</text>
				<quoted-block id="HFE61FA748AD14A16A4F40348FB6C1E9B" style="OLC">
					<subsection id="H663CEB4C60A14E7891ED768CFBD478D5"><enum>(e)</enum><header>Limited income newly eligible transition program</header>
 <paragraph id="H6BD400E1777A4DB8993C082924692C7E"><enum>(1)</enum><header>In general</header><text>The Secretary shall carry out a program to provide transitional coverage for covered part D drugs for LI NET eligible individuals in accordance with this subsection.</text>
 </paragraph><paragraph id="HE4822F2191214219A28D84E4CD1A1D85"><enum>(2)</enum><header>LI net eligible individual defined</header><text>For purposes of this subsection, the term <term>LI NET eligible individual</term> means a part D eligible individual who—</text> <subparagraph id="H39595274B6C643CC9E4306662F6C0D6E"><enum>(A)</enum><text>is a subsidy eligible individual; and</text>
 </subparagraph><subparagraph id="H6F213F99C51149C9ADEAF447F466A975"><enum>(B)</enum><text>has not yet enrolled in a prescription drug plan or an MA–PD plan, or, who has so enrolled, but with respect to whom coverage under such plan has not yet taken effect.</text>
 </subparagraph></paragraph><paragraph id="H66C22860FBB44D64A26A66245D47FE75"><enum>(3)</enum><header>Transitional coverage</header><text>For purposes of this subsection, the term <term>transitional coverage</term> means with respect to an LI NET eligible individual—</text> <subparagraph id="H98C1D8DAAD9D447FA71D5FDAB6EC73B7"><enum>(A)</enum><text>immediate access to covered part D drugs at the point of sale during the period that begins on the first day of the month such individual is determined to be a subsidy eligible individual and ends on the date that coverage under a prescription drug plan or MA–PD plan takes effect with respect to such individual; and</text>
 </subparagraph><subparagraph id="H4E8428C5F8304A3296BFD033B80BCE34"><enum>(B)</enum><text>in the case of an LI NET eligible individual who is a full-benefit dual eligible individual (as defined in section 1935(c)(6)) or a recipient of supplemental security income benefits under title XVI, retroactive coverage (in the form of reimbursement of the amounts that would have been paid under this part had such individual been enrolled in a prescription drug plan or MA–PD plan) of covered part D drugs purchased by such individual during the period that begins on the date that is the later of—</text>
 <clause id="HE8640A1D9E88437DA2724F4B13A79E9E"><enum>(i)</enum><text>the date that such individual was first eligible for a low-income subsidy under this part; or</text> </clause><clause id="H55E8FDC9FB124ABAB312CC3E85EB9F24"><enum>(ii)</enum><text>the date that is 36 months prior to the date such individual enrolls in a prescription drug plan or MA–PD plan,</text>
								</clause><continuation-text continuation-text-level="subparagraph">and ends on the date that coverage under such plan takes effect.</continuation-text></subparagraph></paragraph><paragraph id="H399D4652085645258A4DD8CDE2E96DD1"><enum>(4)</enum><header>Program administration</header>
 <subparagraph id="H72A39D252436453F84E2BECDE41DBCF5"><enum>(A)</enum><header>Single point of contact</header><text>The Secretary shall, to the extent feasible, administer the program under this subsection through a contract with a single program administrator.</text>
 </subparagraph><subparagraph id="HF20B46663F364F31969BC9F7ADD4405B"><enum>(B)</enum><header>Benefit design</header><text>The Secretary shall ensure that the transitional coverage provided to LI NET eligible individuals under this subsection—</text>
 <clause id="H8B865260BEE945C691221CB1715DD400"><enum>(i)</enum><text>provides access to all covered part D drugs under an open formulary;</text> </clause><clause id="H2488FFB062CE4B90B7A9741DED4980CA"><enum>(ii)</enum><text>permits all pharmacies determined by the Secretary to be in good standing to process claims under the program;</text>
 </clause><clause id="H6B36B141B454446F93126B15633D73D6"><enum>(iii)</enum><text>is consistent with such requirements as the Secretary considers necessary to improve patient safety and ensure appropriate dispensing of medication; and</text>
 </clause><clause id="HE362B2C451B44DE9A3F50F8828BA4D29"><enum>(iv)</enum><text>meets such other requirements as the Secretary may establish.</text> </clause></subparagraph></paragraph><paragraph id="HC777F91B533F427BA09652B7187C408C"><enum>(5)</enum><header>Relationship to other provisions of this title; waiver authority</header> <subparagraph id="HA13733F9F783493CB45151DCF18B7790"><enum>(A)</enum><header>In general</header><text>The following provisions shall not apply with respect to the program under this subsection:</text>
 <clause id="HBDCC43E9CD9B49D8819E71BC895A0F00"><enum>(i)</enum><text>Paragraphs (1) and (3)(B) of section 1860D–4(a) (relating to dissemination of general information; availability of information on changes in formulary through the internet).</text>
 </clause><clause id="H481BE8BB5C0946B48F67940CEABD555A"><enum>(ii)</enum><text>Subparagraphs (A) and (B) of section 1860D–4(b)(3) (relating to requirements on development and application of formularies; formulary development).</text>
 </clause><clause id="HCA397D3A6F59466DB0C0EA803B3F3271"><enum>(iii)</enum><text>Paragraphs (1)(C) and (2) of section 1860D–4(c) (relating to medication therapy management program).</text>
 </clause></subparagraph><subparagraph id="HD1B3266E23944D4CBE4943E13834E00E"><enum>(B)</enum><header>Waiver authority</header><text>The Secretary may waive such other requirements of titles XI and this title as may be necessary to carry out the purposes of the program established under this subsection.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body></bill>


